Skip to main content
ASTRO 2024 Main banner
Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis
Back
Main Session

EDU 19 - Is Consolidation Radiotherapy Still Needed for Lymphoma in 2024? Reappraisal in Light of Recent Trials Results

Combined Modality Treatment Remains the Gold-Standard for Early Hodgkin Lymphoma

Monday, September 30, 2024
8:17 AM – 8:32 AM ET
Location: Room 143

Learning Objectives:

  1. Explain the data supporting combined modality treatment in early Hodgkin lymphoma and quantify the benefit for individual patients.
  2. Determine which patients with Primary Mediastinal B-cell Lymphoma benefit from consolidation radiotherapy.
  3. Assess disease and patient factors to select patients for consolidation RT in DLBCL.